{"title":"Reumatología a la calle, la gran apuesta de PANLAR 2024","authors":"E. Fajardo","doi":"10.46856/grp.233.e187","DOIUrl":"https://doi.org/10.46856/grp.233.e187","url":null,"abstract":"Con el doctor Miguel Albanese, presidente de PANLAR, exploramos lo que Barranquilla tiene para sorprendernos. Reumatología a la calle es el legado que se busca dejar como muestra de la integración con la población.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"11 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140738710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PANLAR 2024, Barranquilla brings an academic program for all interests","authors":"Estefanía Fajardo","doi":"10.46856/grp.233.et188","DOIUrl":"https://doi.org/10.46856/grp.233.et188","url":null,"abstract":"Manuel Ugarte, president of the Scientific Committee of the PANLAR 2024 Congress, discusses the main topics of the event, as well as the integration with other specialties and patient groups. A program for all tastes, interests, and audiences.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"9 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140738523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PANLAR 2024, Barranquilla traz um programa acadêmico para todos os interesses","authors":"Estefanía Fajardo","doi":"10.46856/grp.233.ept188","DOIUrl":"https://doi.org/10.46856/grp.233.ept188","url":null,"abstract":"Manuel Ugarte, presidente do Comitê Científico do Congresso PANLAR 2024, fala sobre os principais temas do evento, bem como sobre a integração com outras especialidades e grupos de pacientes. Um programa para todos os gostos, interesses e públicos.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"28 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140740049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Patient-Centered Medicine Takes Center Stage at PANLAR 2024","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.et184","DOIUrl":"https://doi.org/10.46856/grp.27.et184","url":null,"abstract":"This year, in addition to the VII Pan American Congress of Patients with Rheumatic Diseases, patients will have an active role in the development of PANLAR 2024 Congress within the scientific program and community activities.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"33 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140797146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diretrizes de Prática Clínica para Artrite Reumatoide da PANLAR: Uma Abordagem Abrangente para Todos","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.ept185","DOIUrl":"https://doi.org/10.46856/grp.27.ept185","url":null,"abstract":"Após 15 anos, a PANLAR atualizará as diretrizes para Artrite Reumatoide (AR) visando abordar as especificidades dos sistemas de saúde e o manejo da doença nos países membros. Além disso, espera que sejam amigáveis para diversos públicos estratégicos.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"124 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medicina centrada en los pacientes, un rol protagónico en PANLAR 2024","authors":"E. Fajardo","doi":"10.46856/grp.27.e184","DOIUrl":"https://doi.org/10.46856/grp.27.e184","url":null,"abstract":"Este año, adicional al VII Congreso Panamericano de Pacientes con Enfermedades Reumáticas, contarán con participación activa en el desarrollo del Congreso PANLAR 2024 en el marco del programa científico y actividades con la comunidad.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"413 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140757626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Global Rheumatology becomes the official journal of PANLAR","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.et186","DOIUrl":"https://doi.org/10.46856/grp.27.et186","url":null,"abstract":"Framed within the scientific dissemination in Rheumatology, GR will have a special participation in PANLAR 2024 with a narrative workshop. The commitment of the journal to maintain and strengthen standards of quality and excellence in the dissemination of scientific knowledge remains.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"371 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140773377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Global Rheumatology se convierte en la revista oficial de PANLAR","authors":"E. Fajardo","doi":"10.46856/grp.27.e186","DOIUrl":"https://doi.org/10.46856/grp.27.e186","url":null,"abstract":"Enmarcada en la difusión científica en Reumatología, GR tendrá participación especial en PANLAR 2024 con un taller de narrativas. El compromiso de la revista con mantener y fortalecer los estándares de calidad y excelencia en la difusión del conocimiento científico se mantiene.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"56 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140775060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Practice Guidelines for Rheumatoid Arthritis PANLAR: A Comprehensive Approach for All","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.et185","DOIUrl":"https://doi.org/10.46856/grp.27.et185","url":null,"abstract":"After 15 years, PANLAR will update the Rheumatoid Arthritis (RA) guidelines, aiming to address the specificities of healthcare systems and disease management in its member countries. Additionally, it hopes to make them user-friendly for diverse strategic audiences.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"8 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140765413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Certolizumab pegol in severe rheumatoid arthritis: Real-world evidence in an Argentine cohort: Achievement of targets (T2T) at 3 months and predictive factors.","authors":"R. G. García Salinas, S. Magri, Álvaro Ruta","doi":"10.46856/grp.10.et182","DOIUrl":"https://doi.org/10.46856/grp.10.et182","url":null,"abstract":"Introduction: Certolizumab pegol (CTZ) is a tumor necrosis factor-alpha (TNF-α) inhibitor biological agent that has demonstrated efficacy in controlling rheumatoid arthritis (RA). Identifying predictive factors for treatment success and assessing its effectiveness in a real-world clinical setting are crucial for decision-making. Objective: To evaluate the response to CTZ in patients with RA in a real-world cohort, measuring the reduction in DAS 28, HAQ, frequency of remission, and low disease activity (LDA) at three months, identifying predictive factors, and evaluating the reduction in the use of corticosteroids. Methods: A prospective real-world observational study included patients over 18 years of age with RA (ACR/EULAR 2010 criteria) who initiated CTZ and were followed for three months. Demographic, clinical, comorbidity, treatment, and disease activity data were recorded. Results: Out of 2092 RA patients treated with CTZ between 2016 and 2021, 90% had a poor prognosis, and 60% had high disease activity. Among 1673 patients followed for three months, a reduction in DAS 28 (-1.9) and HAQ (-0.63) was observed. At three months, 10.5% achieved remission, and 40% achieved LDA. Predictive factors for remission included age (OR: 0.97) and DAS 28 (OR: 0.58); for LDA, age (OR: 0.97), DAS 28 (OR: 0.61), first-line CTZ (OR: 1.6), and HAQ (OR: 0.61). Additionally, there was a reduction in the use of glucocorticoids (-3.1 mg prednisone). Conclusions: CTZ is effective in RA, emphasizing patient selection and an early treatment approach. This study supports the efficacy of CTZ.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140439324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}